cell cycle staining kit ccs012 (MultiSciences Biotech Co Ltd)
90
Structured Review
MultiSciences Biotech Co Ltd
cell cycle staining kit ccs012
Cell Cycle Staining Kit Ccs012, supplied by MultiSciences Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+cycle+staining+kit/cell+cycle+staining+kit+ccs012/pm38467320-87-3-9
Average 90 stars, based on 1 article reviews
Cell Cycle Staining Kit Ccs012, supplied by MultiSciences Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+cycle+staining+kit/cell+cycle+staining+kit+ccs012/pm38467320-87-3-9
Average 90 stars, based on 1 article reviews
cell cycle staining kit ccs012 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Flow Cytometry:Article Title: Targeted Degradation of the Estrogen Receptor α through Unconventional Coactivator Binding Site (CBS). Article Snippet: Inhibiting the estrogen receptor α (ERα) signaling axis constitutes a fundamental approach in therapy for ERαpositive breast cancer (ERα+ BC).. However, the emergence of intrinsic and acquired resistance to endocrine therapies poses a significant challenge.. Alternatively, targeting the coactivator binding site (CBS) of ERα instead of the conventional ligand binding domain (LBD) may directly disrupt the ERα transcription process, thereby circumventing resistance associated with LBD mutations. Staining:Article Title: Targeted Degradation of the Estrogen Receptor α through Unconventional Coactivator Binding Site (CBS). Article Snippet: Inhibiting the estrogen receptor α (ERα) signaling axis constitutes a fundamental approach in therapy for ERαpositive breast cancer (ERα+ BC).. However, the emergence of intrinsic and acquired resistance to endocrine therapies poses a significant challenge.. Alternatively, targeting the coactivator binding site (CBS) of ERα instead of the conventional ligand binding domain (LBD) may directly disrupt the ERα transcription process, thereby circumventing resistance associated with LBD mutations. Article Title: Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Article Snippet: .. For the cell cycle assay, the cells were stained with Article Title: KCNE3 Facilitates M1 Macrophage Polarization by Suppressing the Wnt/β-Catenin Pathway, Inhibiting Glioma Proliferation, Migration, and Invasion. Article Snippet: The glioma microenvironment is critical for tumor growth, where reprogramming M2‐polarized tumor‐associated macrophages/microglia (TAMs) to an antitumor M1 phenotype represents a promising therapeutic strategy.. While the potassium channel regulatory subunit KCNE3 has been implicated in tumorigenesis across malignancies, its functional role in shaping the glioma microenvironment remains undefined.. Here, we leveraged transcriptome data from the Gene Expression Omnibus (GEO) to identify KCNE3 as a TAM‐enriched gene in gliomas. other:Article Title: Mechanism of berbamine-mediated DNA damage in synovial fibroblasts to alleviate rheumatoid arthritis. Article Snippet: Rheumatoid arthritis (RA) is a common chronic autoimmune disease characterised by the proliferation and infiltration of fibroblast-like synoviocytes (FLS).. However, pharmaceutical approaches to inhibit FLS in the treatment of RA are limited.. Berbamine (BBM), a natural compound extracted from Phellodendron chinense Schneider, has demonstrated anti-tumour and anti-inflammatory effects. Incubation:Article Title: The role of TRAF2 in pan-cancer revealed by integrating informatics and experimental validation Article Snippet: .. We added Article Title: Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α. Article Snippet: .. Subsequently, after a 24-h incubation period, the cells were treated with a Article Title: Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α Article Snippet: .. Subsequently, after a 24-h incubation period, the cells were treated with a Cell Cycle Assay:Article Title: Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α. Article Snippet: .. Subsequently, after a 24-h incubation period, the cells were treated with a Article Title: Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α Article Snippet: .. Subsequently, after a 24-h incubation period, the cells were treated with a Article Title: Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Article Snippet: .. For the cell cycle assay, the cells were stained with |
